(b)(6) clinical study.It was reported that following a coronary artery drug eluting stenting treatment procedure, the patient had myocardial infarction (mi).In (b)(6) 2012, the patient was diagnosed with stable angina (ccs classification: 3) and was referred for cardiac catheterization.The de novo target lesion was located in the proximal right coronary artery (prox rca) with 80% stenosis and was 10 mm long with a reference vessel diameter of 3.0 mm.The target lesion was treated with direct placement of a 3.00 x 12 mm promus element plus stent.Following post-dilatation, residual stenosis was 0%.The patient was discharged on aspirin and ticagrelor the next day.In (b)(6) 2017, the patient was presented to emergency department with shortness of breath and chest discomfort and the patient was referred for further evaluation.During the course at emergency department, the patient¿s pain returned.The patient¿s cardiac enzymes were noted to be elevated and the site reported an event of non st-elevation myocardial infarction (nstemi).Baseline enzymes were not withdrawn.Hence, the patient was admitted to the hospital for further diagnosis.During hospitalization the patient¿s shortness of breath worsened and the patient was diagnosed with acute exacerbation of chronic obstructive pulmonary disease (copd), anemia and thrombocytopenia.Further, the patient was referred for cardiac catheterization and possible intervention.Two days later, the 90% stenosis located in distal rca was treated with pre-dilatation and placement of a 2.75 x 28 mm non-bsc drug-eluting stent.Following post-dilatation, completion angiogram showed excellent results without thrombosis, perforation or dissection.The event was considered resolved and was recommended for cardiac rehabilitation.Two days later, the patient was discharged on aspirin and ticagrelor.
|